Nutriband Partners with Kindeva to Develop Abuse-Deterrent Fentanyl Patch
I'm PortAI, I can summarize articles.
Nutriband Inc. has partnered with Kindeva to develop AVERSA™ Fentanyl, an abuse-deterrent transdermal fentanyl patch. This collaboration combines Nutriband’s AVERSA™ technology with Kindeva’s FDA-approved fentanyl patch to improve safety and deter misuse while ensuring effective pain management for patients.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments